COO - Cooper Companies (The)
93.44
| Index: | S&P 500 | P/E: | 47.78 | EPS (ttm): | 1.96 | Insider Own: | 0.50% | Shs Outstand: | 199.60M | Perf Week: | -1.49% |
| Market Cap: | 18.96B | Forward P/E: | 20.97 | EPS next Y: | 4.46 | Insider Trans: | -20.18% | Shs Float: | 198.58M | Perf Month: | -5.69% |
| Income(ttm): | 392.30M | PEG: | 4.55 | EPS next Q: | 0.91 | Inst Own: | 97.66% | Short Float: | 1.21% | Perf Quarter: | -14.91% |
| Revenue(ttm): | 3.90B | P/S: | 4.87 | EPS this Y: | 8.12% | Inst Trans: | -1.01% | Short Ratio: | 1.81 | Perf Half Y: | 4.04% |
| Book/sh: | 40.50 | P/B: | 2.31 | EPS next Y: | 11.71% | ROA: | 3.27% | Short Interest: | 2.39M | Perf Year: | 3.72% |
| Cash/sh: | 0.53 | P/C: | 176.00 | EPS next 5Y: | 10.50% | ROE: | 5.02% | 52W Range: | 84.76 - 112.38 | Perf YTD: | -1.24% |
| Dividend Est.: | 0.03 (0.03%) | P/FCF: | 65.79 | EPS past 5Y: | -3.45% | ROI: | 3.61% | 52W High: | -16.85% | Beta: | 0.99 |
| Dividend TTM: | - | Quick Ratio: | 1.12 | Sales past 5Y: | 8.41% | Gross Margin: | 61.47% | 52W Low: | 10.24% | ATR (14): | 2.35 |
| Dividend Ex-Date: | Jul 26, 2023 | Current Ratio: | 1.91 | EPS Y/Y TTM: | 32.56% | Oper. Margin: | 18.12% | RSI (14): | 32.35 | Volatility: | 2.49% 2.31% |
| Employees: | 16000 | Debt/Eq: | 0.35 | Sales Y/Y TTM: | 8.41% | Profit Margin: | 10.07% | Recom: | 1.95 | Target Price: | 115.57 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.34 | EPS Q/Q: | 38.00% | Payout: | 0.00% | Rel Volume: | 2.10 | Prev Close: | 91.93 |
| Sales Surprise: | -0.82% | EPS Surprise: | 3.98% | Sales Q/Q: | 9.85% | Earnings: | Dec 05 AMC | Avg Volume: | 1.32M | Price: | 93.44 |
| SMA20: | -5.73% | SMA50: | -8.63% | SMA200: | -4.64% | Undervalued: 23.68% | Volume: | 2,784,859 | Change: | 1.64% | |
Graham Classic formula value: 51.92
(P/E=8 * 1g) Min value: 32.56
(current P/E * 2g) Max value: 121.05
Average value: 68.51
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.